Zivo Bioscience Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
25.70
25.00
25.00
25.00
18.80
-
Gross Income
25.70
25.00
25.00
25.00
18.80
-
SG&A Expense
3,084.50
3,736.90
3,031.30
3,465.40
6,311.40
6,130.60
EBIT
3,110.20
3,761.90
3,056.30
3,490.40
6,330.20
6,130.60
Unusual Expense
1,001.90
7,002.90
-
-
406.50
-
Non Operating Income/Expense
-
-
34.90
-
7.40
-
Interest Expense
5,983.80
2,560.30
2,767.80
2,569.20
3,309.10
8,504.70
Pretax Income
10,095.90
680.80
5,789.10
6,059.60
10,038.40
14,635.40
Consolidated Net Income
10,095.90
680.80
5,789.10
6,059.60
10,038.40
14,635.40
Net Income
10,095.90
680.80
5,789.10
6,059.60
10,038.40
14,635.40
Net Income After Extraordinaries
10,095.90
680.80
5,789.10
6,059.60
10,038.40
14,635.40
Net Income Available to Common
10,095.90
680.80
5,789.10
6,059.60
10,038.40
14,635.40
EPS (Basic)
0.09
0.00
0.04
0.05
0.07
0.09
Basic Shares Outstanding
112,214.10
125,327.10
130,946.00
133,844.30
139,243.10
156,678.80
EPS (Diluted)
0.09
0.00
0.04
0.05
0.07
0.09
Diluted Shares Outstanding
112,214.10
182,205.00
130,946.00
133,844.30
139,243.10
156,678.80
EBITDA
3,084.50
3,736.90
3,031.30
3,465.40
6,311.40
6,130.60
About Zivo Bioscience
View Profile
